Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06107361 · ClinicalTrials.gov registry record · NA
Evaluating the Role of the Guidewire in Peripheral Intravenous Access: A Randomized Controlled Trial of Ultrasound-Guided Catheter Survival
A NA study of Peripheral Intravenous Vein Catheter Phlebitis and Intravenous Infection, sponsored by Corewell Health East.
- Recruiting
- Registry status
- NA
- Development phase
- 360
- Enrollment target
- 1
- Study location
NCT06107361 is a NA study of Peripheral Intravenous Vein Catheter Phlebitis and Intravenous Infection that is actively recruiting participants, run by Corewell Health East. The registered enrollment target is 360 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06107361, a NA study of Peripheral Intravenous Vein Catheter Phlebitis and Intravenous Infection, is actively recruiting participants, sponsored by Corewell Health East.
- RECRUITING
- Registry status
- NA
- Development phase
- 360 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, parallel, non-blinded, two-arm randomized controlled trial of intravenous catheter failure evaluating the impact of a built-in guide wire. The objective of this study is to demonstrate that the control ultralong intravenous catheter (IV) without the guide wire is non-inferior to the experimental catheter with the guide wire. After obtaining consent, eligible patients will be randomly allocated to control Arm 1 (ultralong intravenous catheter) or experimental Arm 2 (ultralong intravenous catheter with guide wire) in a ratio of 1:1 via a computer-generated randomization schedule. The participants will be followed to collect data until the catheter is removed.
Conditions Studied
Interventions
- DEVICE B. Braun 6.35cm 20 gauge ultralong intravenous catheter
- DEVICE BD 5.71 cm 20 gauge Accucath
Study Locations (1)
Michigan
- Beaumont Hospital - Royal Oak - Royal Oak
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2023-11-07 |
| Est. Completion | 2026-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06107361
The ClinicalTrials.gov registry entry for NCT06107361 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Peripheral Intravenous Vein Catheter Phlebitis appearing as the primary indexed condition, and to 2 interventions - of which B. Braun 6.35cm 20 gauge ultralong intravenous catheter is the first listed.
NCT06107361 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT06107361 about?
NCT06107361 is a clinical study titled "Evaluating the Role of the Guidewire in Peripheral Intravenous Access: A Randomized Controlled Trial of Ultrasound-Guided Catheter Survival". This is a prospective, parallel, non-blinded, two-arm randomized controlled trial of intravenous catheter failure evaluating the impact of a built-in guide wire. The objective of this study is to demonstrate that the control ultralong intravenous catheter (IV) without the guide wire is non-inferior ...
What is the current status of trial NCT06107361?
This trial is currently recruiting. It is a NA study. The enrollment target is 360 participants. The study started on 2023-11-07. Estimated completion is 2026-05.
What conditions does trial NCT06107361 study?
This clinical trial studies the following conditions: Peripheral Intravenous Vein Catheter Phlebitis, Intravenous Infection.
What interventions are being tested in trial NCT06107361?
The interventions under investigation include: B. Braun 6.35cm 20 gauge ultralong intravenous catheter (DEVICE), BD 5.71 cm 20 gauge Accucath (DEVICE).
Who is sponsoring clinical trial NCT06107361?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06107361 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Peripheral Intravenous Vein Catheter Phlebitis
All registered trials for this condition
Intravenous Infection
All registered trials for this condition
Michigan
All trials with a study site in Michigan
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.